PIM
CLVS

Partner Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Partner Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,000
Closed -$264K – 121
2018
Q3 		$264K Hold
9,000
– – 0.2% 93
2018
Q2 		$409K Buy
+9,000
New +$438K 0.33% 86
2016
Q2 		– Sell
-13,400
Closed -$257K – 105
2016
Q1 		$257K Buy
13,400
+7,900
+144% +$167K 0.42% 60
2015
Q4 		$193K Buy
+5,500
New +$355K 0.32% 57

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Partner Investment Management's CLVS Position: Q4 2018 in Review

Partner Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 27,957 shares — an estimated $821K sold.

Partner Investment Management first reported a position in CLVS in Q2 2013 and held it in 20 quarters. The position peaked at $12.1M in Q4 2013. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • Partner Investment Management reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • Partner Investment Management sold 27,957 Clovis Oncology, Inc. shares in Q4 2018, an estimated $821K.
  • Partner Investment Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 20 quarters.
  • Partner Investment Management's Clovis Oncology, Inc. position peaked at $12.1M in Q4 2013.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Partner Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.